Development of radioligands for the dopamine transporter
Development of radioligands for the dopamine transporter
复制标题
DOI:
10.1007/bf02040050
复制
发表时间:
1996-05
影响因子:
1.6
通讯作者:
L. Müller;C. Halldin;C. Lundkvist;C. Swahn;C. Foged;H. Hall;P. Karlsson;N. Ginovart;Y. Nakashima;T. Suhara;L. Farde
中科院分区:
文献类型:
--
作者:
L. Müller;C. Halldin;C. Lundkvist;C. Swahn;C. Foged;H. Hall;P. Karlsson;N. Ginovart;Y. Nakashima;T. Suhara;L. Farde
Degree: Fil. Dr.DegreeYear: 1994Institute: Karolinska Institutet (Sweden)The dopamine transporter, a protein localized to the presynaptic dopamine neuron, has been suggested as a marker for degenerative brain disorders such as Parkinson''s and Alzheimer''s disease. The aim was to develop new radioligands for the examination of the dopamine transporter in the living human brain by positron emission tomography. Compounds belonging to two different chemical classes, the benzhydryl substituted piperazine derivatives and 3-substituted analogues of cocaine were radiolabelled with different radionuclides. The comparatively long lived radionuclidesH,Br andI were used to label radioligands for studies on brain homogenates in vitro.C,F andBr were used for autoradiographic studies in vitro or for PET studies in vivo on monkey and humans.